Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Receivables - Net (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Receivables - Net data on record, last reported at $25.5 million in Q4 2025.

  • For Q4 2025, Receivables - Net fell 33.81% year-over-year to $25.5 million; the TTM value through Dec 2025 reached $25.5 million, down 33.81%, while the annual FY2025 figure was $25.5 million, 33.81% down from the prior year.
  • Receivables - Net reached $25.5 million in Q4 2025 per MRVI's latest filing, up from $22.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $138.6 million in Q4 2022 and bottomed at $22.5 million in Q3 2025.
  • Average Receivables - Net over 5 years is $66.5 million, with a median of $51.8 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: soared 130.33% in 2021, then crashed 60.61% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $117.5 million in 2021, then grew by 17.97% to $138.6 million in 2022, then plummeted by 60.61% to $54.6 million in 2023, then fell by 29.46% to $38.5 million in 2024, then crashed by 33.81% to $25.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $25.5 million in Q4 2025, $22.5 million in Q3 2025, and $27.9 million in Q2 2025.